Marimed (MRMD) Net Equity Issued and Repurchased (2016 - 2019)

Marimed (MRMD) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $150000.0 in Q4 2019.

• On a quarterly basis, Net Equity Issued and Repurchased fell 98.99% year-over-year to $150000.0 in Q4 2019; TTM through Dec 2019 was $17.7 million, a 44.45% decrease from a year earlier, with the FY2019 full-year figure at $2.8 million, down 91.36% from the prior year.
• Net Equity Issued and Repurchased for Q4 2019 stood at $150000.0, down from $2.6 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for MRMD reached as high as $14.9 million in Q4 2018 and fell as low as -$50000.0 in Q3 2017.
• Historically, Net Equity Issued and Repurchased has averaged $3.8 million across 4 years, with a median of $1.4 million in 2017.
• Across the five-year window, Net Equity Issued and Repurchased jumped 16969.99% in 2018 and sank 98.99% in 2019, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $200000.0 in 2016, then soared by 617.9% to $1.4 million in 2017, then surged by 939.49% to $14.9 million in 2018, then sank by 98.99% to $150000.0 in 2019.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $150000.0 in Q4 2019, $2.6 million in Q1 2019, and $14.9 million in Q4 2018.